User profiles for Moises A Huaman

Moises A Huaman, MD MSc

University of Cincinnati, Cincinnati, OH
Verified email at uc.edu
Cited by 2481

[HTML][HTML] Early outpatient treatment for Covid-19 with convalescent plasma

…, ES Spivak, S Anjan, MA Huaman… - … England Journal of …, 2022 - Mass Medical Soc
Background Polyclonal convalescent plasma may be obtained from donors who have
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …

Coronavirus disease 2019 convalescent plasma outpatient therapy to prevent outpatient hospitalization: a meta-analysis of individual participant data from 5 …

AC Levine, Y Fukuta, MA Huaman, J Ou… - Clinical Infectious …, 2023 - academic.oup.com
Background Outpatient monoclonal antibodies are no longer effective and antiviral treatments
for coronavirus disease 2019 (COVID-19) disease remain largely unavailable in many …

Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern

…, ER Cachay, BR Meisenberg, MA Huaman… - Blood …, 2022 - ashpublications.org
The ongoing evolution of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
variants severely limits available effective monoclonal antibody therapies. Effective drugs are …

[HTML][HTML] Tuberculosis and cardiovascular disease: linking the epidemics

MA Huaman, D Henson, E Ticona, TR Sterling… - Tropical diseases, travel …, 2015 - Springer
The burden of tuberculosis and cardiovascular disease (CVD) is enormous worldwide. CVD
rates are rapidly increasing in low- and middle-income countries. Public health programs …

[HTML][HTML] Prevalence, risk factors, and treatment outcomes of isoniazid-and rifampicin-mono-resistant pulmonary tuberculosis in Lima, Peru

L Villegas, L Otero, TR Sterling, MA Huaman… - PloS one, 2016 - journals.plos.org
Background Isoniazid and rifampicin are the two most efficacious first-line agents for
tuberculosis (TB) treatment. We assessed the prevalence of isoniazid and rifampicin mono-…

[HTML][HTML] Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

…, SL Heath, B Meisenberg, MA Huaman… - The Lancet …, 2023 - thelancet.com
Background Cytokines and chemokines play a critical role in the response to infection and
vaccination. We aimed to assess the longitudinal association of COVID-19 vaccination with …

[HTML][HTML] Randomized controlled trial of early outpatient COVID-19 treatment with high-titer convalescent plasma

…, BR Meisenberg, ES Spivak, S Anjan, MA Huaman… - Medrxiv, 2021 - ncbi.nlm.nih.gov
BACKGROUND: The efficacy of polyclonal high titer convalescent plasma to prevent
serious complications of COVID-19 in outpatients with recent onset of illness is uncertain. …

Assessment of coronary artery disease with computed tomography angiography and inflammatory and immune activation biomarkers among adults with HIV eligible …

…, ME Sobieszczyk, M Mall, MS Huaman… - JAMA Network …, 2021 - jamanetwork.com
Importance Cardiovascular disease (CVD) is increased among people with HIV (PWH), but
little is known regarding the prevalence and extent of coronary artery disease (CAD) and …

Treatment of latent tuberculosis infection—an update

MA Huaman, TR Sterling - Clinics in chest medicine, 2019 - chestmed.theclinics.com
Latent tuberculosis infection (LTBI) is defined by the presence of detectable immune responses
to Mycobacterium tuberculosis antigens with no clinical evidence of active TB disease. 1 …

The relationship between latent tuberculosis infection and acute myocardial infarction

MA Huaman, E Ticona, G Miranda… - Clinical Infectious …, 2018 - academic.oup.com
Background Tuberculosis has been associated with an increased risk of cardiovascular
disease (CVD), including acute myocardial infarction (AMI). We investigated whether latent …